"Children 5-11 years of age generally present with mild or asymptomatic SARS-CoV-2 infection.
Among the 12 jurisdictions currently reporting detailed age data to PHAC, severe outcomes from
COVID-19 such as hospitalization and death are very infrequent in children, occurring in <0.3%
and <0.002% of confirmed SARS-CoV-2 infections in children aged 5-11 years. As of November
09, 2021, children aged 5-11 years represent 7.5% of confirmed SARS-CoV-2 infections, 0.3% of
COVID-19 associated hospitalizations, 0.3% of COVID-19 associated ICU admissions, and
0.007% of COVID-19 deaths in Canada (3)"
We have been saying this all along. No need for pharmaceutical intervention until the risks are known.